dc.description.abstract | Objective: Dyslipidemias, primarily hypercholesterolemia, are independent and strong predictors of cardiovascular (CV) events. The frequency of dyslipidemia is very important in terms of determining CV prevention policies. In order to determine the up-to-date frequency of CV risk factors in Turkey, a meta-analysis of the epidemiologic studies carried out in the last 15 years was performed. This article presents the results on the dyslipidemia data including hypercholesterolemia principally. Methods: Epidemiological studies conducted during the last 15 years and having the potential to represent the general population in Turkey were searched in databases (Ovid Medline, Web of Science Core Collection, and Turkish Academic Network and Information Center [ULAKBIM]) and web pages (Ministry of Health, Turkey Statistical Institute, Turkish Society of Cardiology, Nephrology and Endocrinology Associations). A total of 7 studies including lipid data were found. Systematic review and meta-analysis of the studies with low bias score were performed. Crude values of the prevalence of hypercholeterolemia, hypertriglyceridemia and low HDL and mean lipid levels were calculated. Random effects model was used in meta-analysis. Results: The prevalence of hypercholesterolemia defined as a LDL-cholesterol > 130 and/or >= 130 mg/dL, was 29.1% (95% CI 23.6-35.0) in the general population, 30.2% in females (%95 CI 24.7-36.1), and 27.8% in males (95% CI 22.3-33.6). The prevalence of low HDL-cholesterol (<= 50 mg/dL for females and <= 40 mg/dL for males) was calculated as 46.1% (95% CI 42.4-49.9) in the whole group, 50.7% (95% CI 47.7-53.6) in females and 41.1% (95% CI 36.1-46.3) in males. The prevalence of hypertriglyceridemia (> 150 mg/dL) was 36.5% (95% CI 30.6-42.5) in general, 32.0% (95% GA 26.6-37.8) in females and 41.3% (95% CI 34.9-47.8) in males. Conclusion: Dyslipidemia constitutes a major public health problem in Turkey. In the adult population, almost 3 of 10 have hypercholesterolemia, one of 2 has a low HDL-cholesterol, and 1 of 3 has high triglycerides levels. | en_US |
dc.contributor.department | [Kayikcioglu, Meral] Ege Univ, Tip Fak, Kardiyol Anabilim Dali, Izmir, Turkey -- [Tokgozoglu, Lale -- Ozer, Necla] Hacettepe Univ, Tip Fak, Kardiyol Anabilim Dali, Ankara, Turkey -- [Kilickap, Mustafa -- Goksuluk, Huseyin] Ankara Univ, Tip Fak, Kardiyol Anabilim Dali, Ankara, Turkey -- [Karaaslan, Doruk] Koc Univ, Tip Fak, Istanbul, Turkey -- [Abaci, Adnan] Gazi Univ, Tip Fak, Kardiyol Anabilim Dali, Ankara, Turkey -- [Yilmaz, Mehmet Birhan] Cumhuriyet Univ, Tip Fak, Kardiyol Anabilim Dali, Sivas, Turkey -- [Barcin, Cem] Saglik Bilimleri Univ, Gulhane Egitim & Arastirma Hastanesi, Kardiyol Anabilim Dali, Ankara, Turkey -- [Ates, Kenan] Ankara Univ, Tip Fak, Nefrol Bilim Dali, Ankara, Turkey -- [Bayram, Fahri] Erciyes Univ, Tip Fak, Ic Hastaliklari Anabilim Dali, Kayseri, Turkey -- [Sahin, Mahmut] Ondokuz Mayis Univ, Tip Fak, Kardiyol Anabilim Dali, Samsun, Turkey -- [Ural, Dilek] Koc Univ, Tip Fak, Kardiyol Anabilim Dali, Istanbul, Turkey | en_US |